心肌再灌注逆转心肌梗死后左室功能不全和心衰患者心血管风险与舒张压的J型曲线关系:EPHESUS试验启示
EPHESUS试验事后分析纳入5929例急性心肌梗死后左室功能不全、心衰症状或糖尿病患者的资料,按再灌注状态分层,采用Cox回归评估舒张压与心血管结局的关系。结果发现,未再灌注患者舒张压<70 mmHg与全因死亡、心血管死亡及心血管死亡或住院风险增加相关,而再灌注患者中该低舒张压风险消失;低收缩压风险与再灌注状态无关。结论提示低舒张压风险可能涉及冠状动脉灌注压,再灌注治疗可改变此关联。
要点
- 未再灌注心梗后患者舒张压<70 mmHg与全因死亡及心血管事件风险增加独立相关。
- 再灌注治疗可消除低舒张压相关的心血管风险增加。
- 低收缩压相关风险不受再灌注状态影响,临床需综合评估血压。
核心结论
- 心肌梗死后再灌注治疗可逆转低舒张压与心血管风险之间的J型曲线关联。
研究设计与样本
- EPHESUS试验事后分析,纳入5929例急性心肌梗死伴左室功能不全、心衰症状或糖尿病患者,按再灌注状态分层,采用Cox回归模型调整分析。
主要发现
- 未再灌注患者中,舒张压<70 mmHg与全因死亡风险增加相关(调整HR 1.80,95%CI 1.41-2.30;P<0.001)。
- 未再灌注患者中,舒张压<70 mmHg与心血管死亡风险增加相关(调整HR 1.70,95%CI 1.3-3.22;P<0.001)。
- 未再灌注患者中,舒张压<70 mmHg与心血管死亡或心血管住院风险增加相关(调整HR 1.54,95%CI 1.26-1.87;P<0.001)。
- 再灌注患者中未观察到低舒张压相关的风险增加。
- 低收缩压时风险增加与再灌注状态无关;在收缩压120-130 mmHg亚组中,再灌注仍与低舒张压风险降低相关。
临床怎么用
- 对于心肌梗死后左室功能不全或心衰患者,低舒张压(<70 mmHg)提示心血管风险增高,尤其未再灌注者。
- 再灌注治疗可能改变低舒张压的风险关联,支持指南对此类高危患者建议舒张压下限的考虑。
局限性
- 为事后分析,可能存在残余混杂。
- 再灌注状态定义及时间未在摘要中详述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The described association of low diastolic blood pressure (DBP) with increased cardiovascular outcomes could be due to reduced coronary perfusion or is simply due to reverse causation. If DBP is physiologically relevant, coronary reperfusion after myocardial infarction (MI) might influence DBP-risk association. METHODS AND RESULTS: The relation of achieved DBP with cardiovascular death or cardiovascular hospitalization, cardiovascular death, and all-cause death was explored in 5929 patients after acute myocardial infarction (AMI) with impaired left ventricular function, signs and symptoms of heart failure, or diabetes in the EPHESUS trial according to their reperfusion status. Cox regression models were used to assess the impact of reperfusion status on the association of DBP and systolic blood pressure (SBP) with outcomes in an adjusted fashion. In patients without reperfusion, lower DBP <70 mmHg was associated with increased risk for all-cause death [adjusted hazard ratios (HRs) 1.80, 95% confidence interval (CI) 1.41-2.30; P < 0.001], cardiovascular death (HR 1.70, 95% CI 1.3-3.22; P < 0.001), cardiovascular death or cardiovascular hospitalization (HR 1.54, 95% CI 1.26-1.87; P < 0.001). In patients with reperfusion, the risk increase at low DBP was not observed. At low SBP, risk increased independently of reperfusion. A sensitivity analysis in the subgroup of patients with optimal SBP of 120-130 mmHg showed again risk reduction of reperfusion at low DBP. Adding the treatment allocation to eplerenone or placebo into the models had no effects on the results. CONCLUSION: Patients after AMIs with a low DBP had an increased risk, which was sensitive to reperfusion therapy. Low blood pressure after MI identifies in patients with particular higher risk. These data support the hypothesis that low DBP in patients with stenotic coronary lesions is associated with risk, potentially involving coronary perfusion pressure and the recommendations provided by guidelines suggesting lower DBP boundaries for these high-risk patients.
引用
- Böhm M, Ferreira JP, Mahfoud F, et al. Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial. Eur Heart J. 2020. PMID: 32118256. doi:10.1093/eurheartj/ehaa132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。